Extendicare (TSE:EXE – Get Free Report) had its price target hoisted by equities research analysts at TD Securities from C$13.00 to C$15.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage currently has a “hold” rating on the stock. TD Securities’ price objective points to a potential upside of 4.82% from the company’s current price.
EXE has been the subject of a number of other research reports. BMO Capital Markets boosted their target price on shares of Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th.
Check Out Our Latest Report on EXE
Extendicare Stock Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Why Are Stock Sectors Important to Successful Investing?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- What is Short Interest? How to Use It
- 3 Trades Members of Congress Are Making Right Now
- Using the MarketBeat Dividend Tax Calculator
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.